KWS BioTest is now a part of Charles River

In January 2018, Charles River acquired KWS BioTest, a leading contract research organization (CRO) located in Portishead, UK, specializing in in vitro and in vivo discovery testing services for immuno-oncology and inflammatory and infectious diseases. The addition of KWS BioTest’s world-leading immunology expertise makes additional tools available in the increasingly active and promising therapeutic research areas of immunology, oncology, and autoimmune and infectious disease.

If you're ready to discuss a project or have questions, contact us

KWS BioTest logo

Areas of Expertise

Immune responses are involved in nearly every disease area, and there is increasing recognition that the field of immunology intersects with and will open new treatment avenues in many therapeutic areas. If you have a molecule that touches the immune system, we can help. Our areas of expertise include:

Immuno-Oncology

We have developed a platform to profile your new agent in in vitro immuno-oncology assays that mimic this complex biology.

Infection

We can help you with the assessment of novel antimicrobials, antivirals, and vaccines using established in vitro assays and in vivo models.

Autoimmune & Inflammation

We can support your immunology research from early discovery, through in vivo pharmacology, safety assessment, and into clinical studies.

Specialised Capabilities

Specialising in all areas of immunology, with experience testing small molecules, biologics, ADCs and vaccines, KWS BioTest solutions often feature bespoke study designs tailored to meet specific program requirements. Whether working with KWS BioTest alone, or in concert with other Charles River Centers of Excellence, we assist in the design and interpretation of complex programs in target validation, lead optimisation, candidate selection, discovery support, and clinical sample analysis, increasing the chance of molecules succeeding and helping bring them to the clinic faster. Our expanded range of in vivo pharmacology models can assist the efficacy evaluations of your compounds (e.g., infectious disease, inflammation and immunology, ocular disease, SLE). KWS BioTest’s specialised capabilities complement Charles River's services by providing:

Clinical Biomarkers

Predictive Immunotoxicology

Cell Biology

Antiviral and Antimicrobial Testing

In Vivo Pharmacology

Vaccine Development

immune cellOur People

Behind every patient stand thousands of scientists and researchers working together to develop life-saving treatments. Every day, each of us plays a critical role in making a difference in the quality of people's lives.